Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (alirocumab) Injection
Yahoo
Tue, 04/25/17 - 11:04 am
Tags:
Sanofi, Regeneron, FDA, Praluent
Sanofi Sues Mylan Over EpiPen Practices
TheStreet.com
Mon, 04/24/17 - 10:07 pm
Tags:
Sanofi, Mylan Labs, EpiPens
EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
Yahoo/Reuters
Sat, 04/22/17 - 01:14 pm
Tags:
Europe, EMA, Sanofi, Regeneron, rheumatoid arthritis, Kevzara, Sarilumab
Sanofi Epilepsy Drug Responsible for Birth Defects in 4,100 Children, French Regulator Says
TheStreet.com
Fri, 04/21/17 - 11:47 am
Tags:
Sanofi, epilepsy, birth defects, France, Valproate
Meet the lawyer trying to pry drug pricing secrets out of Big Pharma
Stat
Thu, 04/20/17 - 09:02 pm
Tags:
Big Pharma, drug pricing, Mylan Labs, EpiPen, insulin, Eli Lilly, Novo Nordisk, Sanofi
Sanofi says could buy device assets to boost diabetes
Yahoo/Reuters
Thu, 04/20/17 - 09:53 am
Tags:
Sanofi, devices, M&A, diabetes, blood glucose monitoring
When do pharmas disclose launch prices up front? When they’re pricing at a discount
Fierce Pharma
Fri, 04/14/17 - 10:03 am
Tags:
drug discounts, drug pricing, Roche, Neurocrine, Sanofi, Regeneron, Tesaro, Novartis
Sanofi Buying Flexion: A Smart Move?
Motley Fool
Sat, 04/8/17 - 12:47 pm
Tags:
Sanofi, Flexion, M&A, osteoarthritis of the knee
Sanofi May Now Have Moved Past Its Most Challenging Period, Analyst Initiates At Buy
Yahoo/Benzinga
Fri, 04/7/17 - 12:07 am
Tags:
Sanofi, Lantus, Plavix, patents
GSK, Sanofi, Bayer and Lilly join parade of advertisers marching off Fox News host O’Reilly’s TV show
Fierce Pharma
Wed, 04/5/17 - 12:03 pm
Tags:
GSK, Sanofi, Bayer, Eli Lilly, FOX News, drug ads
Sanofi to pay $19 million for VA drug overcharges
Modern Healthcare
Tue, 04/4/17 - 12:20 am
Tags:
Sanofi, veterans, vaccines, DOJ
Lilly, Pfizer, et al. back Sanofi and Regeneron in PCSK9 patent appeal. AbbVie doesn't
Fierce Pharma
Tue, 04/4/17 - 12:13 am
Tags:
Eli Lilly, Pfizer, Sanofi, AbbVie, Regeneron, patents, PCSK9 inhibitors, Repatha
Sanofi boasts observational hypoglycemia rates for Toujeo insulin injection
Mass Device
Tue, 04/4/17 - 12:12 am
Tags:
Sanofi, Toujeo, diabetes, insulin
Regeneron's Game-Changing New Eczema Drug Could Be a Blockbuster
Motley Fool
Thu, 03/30/17 - 09:39 am
Tags:
Regeneron, eczema, Sanofi, Dupixent
Can a $37,000 price be right? For Dupixent, analysts (and one payer) say yes
Fierce Pharma
Wed, 03/29/17 - 11:58 am
Tags:
drug pricing, Dupixent, Sanofi, Regeneron, eczema
As blockbuster drugs fizzle, biotech looks warily to the next big thing
Stat
Wed, 03/29/17 - 11:52 am
Tags:
biotech, Dupixent, Sanofi, Regeneron
FDA approves Regeneron, Sanofi $37,000 per year eczema drug
Yahoo/Reuters
Tue, 03/28/17 - 12:28 pm
Tags:
FDA, Dupixent, Sanofi, Regeneron, eczema
Vivus Inc. stock rises 4.6% after regaining certain commercial rights for Stendra from Sanofi
Marketwatch
Mon, 03/27/17 - 09:52 am
Tags:
Vivus, Stendra, Sanofi, erectile dysfunction
3 Tremendously Promising Diabetes Drugs Potentially on the Way
Motley Fool
Sun, 03/26/17 - 12:02 pm
Tags:
diabetes, ertugliflozin, Merck, Pfizer, sotagliflozin, Sanofi, Lexicon Pharmaceuticals, semaglutide, Novo Nordisk
Sanofi on verge of $1B-plus deal for arthritis-focused biotech Flexion: source
Fierce Pharma
Thu, 03/23/17 - 09:58 pm
Tags:
Sanofi, Flexion, M&A, osteoarthritis of the knee, Zilretta

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.